Oral immunisation of chickens using cholera toxin B subunit and softigenR as adjuvants results in high antibody titre in the egg yolk

In Vivo

Volumn 15, Issue 5, 2001, Pages 381-384

  Hedlund, G P ^a   Hau, J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Animal welfare; Chicken; Cholera toxin; Egg yolk antibody; Hen; IgY; Immunoglobulin Y; Oral immunisation; Pegylated C8 C10 mono diglyceride; Softigen

Indexed keywords

CHOLERA TOXIN B SUBUNIT; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; GLUTARALDEHYDE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN Y ANTIBODY; MACROGOL DERIVATIVE; MACROGOL PLUS C8 ACYLGLYCEROL PLUS C10 DIGLYCERIDE; MICROSPHERE; POLYCLONAL ANTIBODY; POLYGLACTIN; SOFTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG CONJUGATION; EGG YOLK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; QUANTITATIVE ASSAY;

EID: 0034755095     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antibody production without animals
2. The Council Directive on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes
3. Monoclonal and polyclonal antibodies
4. The production of polyclonal antibodies in laboratory animals - The report and recommendations of ECVAM Workshop 35
5. Laboratory animals
6. The rabbit as antibody producer - Advantages and disadvantages
7. Eggs: Conveniently packaged antibodies. Methods for purification of yolk IgG
8. Development and comparison of purification strategies for chicken antibodies from egg yolk
9. Antibody production in rabbits and chickens immunized with human IgG. A comparison of titre and avidity development in rabbit serum, chicken serum and egg yolk using three different adjuvants
10. Selection for hyaluronic acid production traits: Direct and correlated responses in two White Leghorn lines selected for cockerel comb size
11. Incorporation of protein in PLG-microspheres with retention of bioactivity
12. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice
13. Enhancement and suppression of the Peyer's patch immune response by systemic priming
14. Peripheral deletion of antigen-reactive T cells in oral tolerance
15. Tolerance, danger, and the extended family
16. Controlled vaccine release in the gut-associated lymphoid-tissue. Orally-administered biodegradable microspheres target the peyers patches
17. Cholera toxin as a mucosal adjuvant
18. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen
19. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin
20. Enhanced secretory IgA and systemic IgG antibody responses after oral immunizationn with biodegradable microparticles containing antigen
21. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems
22. Mucosal adjuvants
23. Newcastle disease virus strain I2 - A prospective thermostable vaccine for use in developing countries
24. Antigen delivery system
25. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections